Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles

被引：6
|
作者：
Lin, Hung-Yao [1 ]
Tseng, Tai-Chung [1 ,2 ,3 ]
机构：
[1] Natl Taiwan Univ Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Med Res, 1 Chang Te St, Taipei 10002, Taiwan
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2022年 / 28卷 / 02期
关键词：
Tenofovir disoproxil fumarate; Tenofovir alafenamide; Hyperlipidemias; Tenofovir;
D O I：
10.3350/cmh.2022.0028
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：181 / 182
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naive chronic hepatitis B
    Lim, Jihye
    Choi, Won-Mook
    Shim, Ju Hyun
    Lee, Danbi
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Choi, Jonggi
    LIVER INTERNATIONAL, 2022, 42 (07) : 1517 - 1527
  • [22] Long-Term Outcomes after Switching to Tenofovir Alafenamide in Patients with Chronic Hepatitis B
    Nishikawa, Tomohiro
    Matsui, Masahiro
    Onishi, Saori
    Ushiro, Kosuke
    Asai, Akira
    Kim, Soo-Ki
    Nishikawa, Hiroki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (04)
  • [23] Observational pilot study of switching from entecavir to tenofovir alafenamide in patients with chronic hepatitis B
    Matsubara, Takuya
    Hagiwara, Satoru
    Nishida, Naoshi
    Omaru, Naoya
    Yoshida, Akihiro
    Yamamoto, Tomoki
    Komeda, Yoriaki
    Takenaka, Mamoru
    Kudo, Masatoshi
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [24] Impact of switching to tenofovir alafenamide fumarate in patients with entecavir-treated chronic hepatitis B
    Kumada, Takashi
    Toyoda, Hidenori
    Yasuda, Satoshi
    Ito, Takanori
    Tanaka, Junko
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E898 - E904
  • [25] Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
    Chon, Hye Yeon
    Ahn, Sang Hoon
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Jeong-Hoon
    Sinn, Dong Hyun
    Kim, Seung Up
    HEPATOLOGY INTERNATIONAL, 2021, 15 (06) : 1328 - 1336
  • [26] Efficacy and safety of tenofovir alafenamide in patients with chronic hepatitis B exhibiting suboptimal response to entecavir
    Yuan, Gui-Cai
    Chen, Ai-Zhen
    Wang, Wei-Xin
    Yi, Xu-Lan
    Tu, Long
    Peng, Fang
    Qiu, Zhi-Hong
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (34) : 8139 - 8146
  • [27] Impact of switching to tenofovir alafenamide fumarate in patients with entecavir-treated chronic hepatitis B
    Kumada, Takashi
    Toyoda, Hidenori
    Yasuda, Satoshi
    Ito, Takanori
    Tanaka, Junko
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E898 - E904
  • [28] One-year efficacy of tenofovir alafenamide in patients with chronic hepatitis B An observational study
    Chen, Yi-Cheng
    Hsu, Chao-Wei
    Chien, Rong-Nan
    Tai, Dar-In
    MEDICINE, 2022, 101 (25) : E29269
  • [29] Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir
    Wang, Fa-Da
    Zhou, Jing
    Li, Lan-Qing
    Li, Yu-Jing
    Wang, Meng -Lan
    Tao, Ya-Chao
    Zhang, Dong-Mei
    Wang, Yong-Hong
    Chen, En-Qiang
    ANNALS OF HEPATOLOGY, 2023, 28 (05)
  • [30] Tenofovir Alafenamide for Pregnant Chinese Women With Active Chronic Hepatitis B: A Multicenter Prospective Study
    Zeng, Qing-Lei
    Zhang, Hong-Xu
    Zhang, Ji-Yuan
    Huang, Shuo
    Li, Wei-Zhe
    Li, Guang-Ming
    Pan, Ya-Jie
    Feng, Ying-Hua
    Li, Zhi-Qin
    Zhang, Guo-Fan
    Xu, Jiang-Hai
    Lin, Wan-Bao
    Xu, Guang-Hua
    Liu, Na
    Zhang, Guo-Qiang
    Li, Guo-Tao
    Li, Wei
    Zeng, Yan-Li
    Song, Ning
    Wang, Meng
    Zhang, Da-Wei
    Chen, Zhi-Min
    Cui, Guang-Lin
    Li, Juan
    Lv, Jun
    Liu, Yan-Min
    Liang, Hong-Xia
    Sun, Chang-Yu
    Zhou, Yi-Hua
    Yu, Zu-Jiang
    Wang, Fu-Sheng
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (12) : 2826 - +
12345